홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Lidocaine Hydrochloride → Lidocaine

HRID 240242
인쇄

반응식

HRID 240242 반응식
[CH3:1][CH2:2][N:3]([CH2:6][C:7]([NH:9][C:10]1[C:11]([CH3:17])=[CH:12][CH:13]=[CH:14][C:15]=1[CH3:16])=[O:8])[CH2:4][CH3:5].Cl.[OH-].[Na+]>O>[CH3:5][CH2:4][N:3]([CH2:6][C:7]([NH:9][C:10]1[C:15]([CH3:16])=[CH:14][CH:13]=[CH:12][C:11]=1[CH3:17])=[O:8])[CH2:2][CH3:1]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 6314Lidocaine HydrochlorideHCID 14798Sodium Hydroxide

생성물 1

HCID 3676Lidocaine

시약·촉매·용매 1

HCID 962Water용매2회

실험 절차

Sodium chondroitin sulfate (1 g) and lidocaine hydrochloride (2 g) were dissolved in distilled water for injection (80 ml). After being adjusted to pH 6 by addition of a sufficient quantity of sodium hydroxide, the solution was added with distilled water for injection up to the total volume of 100 ml to prepare the composition for local anesthesia of the present invention.

후처리

  1. customto prepare the composition for local anesthesia of the present invention

출처 및 근거

ORD 기록
ord-50ff270e76794733b82acf6060bfe11d
출처 데이터셋
uspto-grants-2014_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08648056B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트